Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sabri

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Appetite|June 26, 2017
Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availabilityA Bresch, M Rullmann, J Luthardt, et al.
Nuklearmedizin. Nuclear Medicine|December 29, 2000
[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease]P Bartenstein, F Grünwald, T Kuwert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathyO Sabri, D Hellwig, M Schreckenberger, et al.
The International Journal of Eating Disorders|September 10, 2016
Emotional eating and in vivo norepinephrine transporter availability in obesity: A [<sup>11</sup> C]MRB PET pilot studyA Bresch, M Rullmann, J Luthardt, et al.
European Journal of Nuclear Medicine|January 19, 2000
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET studyM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenicsO Sabri, R Erkwoh, M Schreckenberger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
European Journal of Nuclear Medicine|November 3, 1998
Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucoseM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Neurology|November 16, 2007
Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic systemF Wegner, K Strecker, J Schwarz, et al.
Nuklearmedizin. Nuclear Medicine|December 30, 1998
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study]M Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Appetite|June 26, 2017
Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availabilityA Bresch, M Rullmann, J Luthardt, et al.
Nuklearmedizin. Nuclear Medicine|December 29, 2000
[Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease]P Bartenstein, F Grünwald, T Kuwert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
Correlation of neuropsychological, morphological and functional (regional cerebral blood flow and glucose utilization) findings in cerebral microangiopathyO Sabri, D Hellwig, M Schreckenberger, et al.
The International Journal of Eating Disorders|September 10, 2016
Emotional eating and in vivo norepinephrine transporter availability in obesity: A [<sup>11</sup> C]MRB PET pilot studyA Bresch, M Rullmann, J Luthardt, et al.
European Journal of Nuclear Medicine|January 19, 2000
"Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET studyM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenicsO Sabri, R Erkwoh, M Schreckenberger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
European Journal of Nuclear Medicine|November 3, 1998
Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucoseM Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Journal of Neurology|November 16, 2007
Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic systemF Wegner, K Strecker, J Schwarz, et al.
Nuklearmedizin. Nuclear Medicine|December 30, 1998
[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study]M Schreckenberger, E Gouzoulis-Mayfrank, O Sabri, et al.
Pageof 12